Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven J Lippmann

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
JMIR Medical Informatics|July 15, 2020
Model-Based Algorithms for Detecting Peripheral Artery Disease Using Administrative Data From an Electronic Health Record Data System: Algorithm Development StudyElizabeth Hope Weissler, Steven J Lippmann, Michelle M Smerek, et al.
Vascular Medicine (London, England)|April 7, 2022
Impact of risk factor control on peripheral artery disease outcomes and health disparitiesF Will Pohlman, Cassie B Ford, E Hope Weissler, et al.
Journal of Cardiac Failure|August 8, 2021
Sacubitril/Valsartan Initiation and Postdischarge Adherence Among Patients Hospitalized for Heart FailureAnthony P Carnicelli, Steven J Lippmann, Stephen J Greene, et al.
JACC. Heart Failure|September 12, 2021
Sacubitril/Valsartan Adherence and Postdischarge Outcomes Among Patients Hospitalized for Heart Failure With Reduced Ejection FractionAnthony P Carnicelli, Zhen Li, Melissa A Greiner, et al.
The American Journal of Cardiology|August 6, 2023
Comparative Outcomes of Sacubitril/Valsartan Use After Hospitalization for Heart Failure Among Medicare Beneficiaries Naïve to Renin-Angiotensin System InhibitorsJacob B Pierce, Vanessa Blumer, Sujung Choi, et al.
American Heart Journal|May 30, 2021
The association of healthcare disparities and patient-specific factors on clinical outcomes in peripheral artery diseaseDennis I Narcisse, Cassie B Ford, E Hope Weissler, et al.
The American Journal of Medicine|October 10, 2021
Clinician Specialty, Access to Care, and Outcomes Among Patients with Peripheral Artery DiseaseE Hope Weissler, Cassie B Ford, Dennis I Narcisse, et al.
Journal of the American Heart Association|February 5, 2019
Relationship Between Hospital Characteristics and Early Adoption of Angiotensin-Receptor/Neprilysin Inhibitor Among Eligible Patients Hospitalized for Heart FailureNancy Luo, Steven J Lippmann, Robert J Mentz, et al.
BMJ Open|January 27, 2023
Construct validity of Patient-Reported Outcomes Measurement Information System Paediatric measures in juvenile idiopathic arthritis and systemic lupus erythematosus: cross-sectional evaluationElissa R Weitzman, Amy Gaultney, Emily von Scheven, et al.
JACC. Heart Failure|April 1, 2017
Early Adoption of Sacubitril/Valsartan for Patients With Heart Failure With Reduced Ejection Fraction: Insights From Get With the Guidelines-Heart Failure (GWTG-HF)Nancy Luo, Gregg C Fonarow, Steven J Lippmann, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
JMIR Medical Informatics|July 15, 2020
Model-Based Algorithms for Detecting Peripheral Artery Disease Using Administrative Data From an Electronic Health Record Data System: Algorithm Development StudyElizabeth Hope Weissler, Steven J Lippmann, Michelle M Smerek, et al.
Vascular Medicine (London, England)|April 7, 2022
Impact of risk factor control on peripheral artery disease outcomes and health disparitiesF Will Pohlman, Cassie B Ford, E Hope Weissler, et al.
Journal of Cardiac Failure|August 8, 2021
Sacubitril/Valsartan Initiation and Postdischarge Adherence Among Patients Hospitalized for Heart FailureAnthony P Carnicelli, Steven J Lippmann, Stephen J Greene, et al.
JACC. Heart Failure|September 12, 2021
Sacubitril/Valsartan Adherence and Postdischarge Outcomes Among Patients Hospitalized for Heart Failure With Reduced Ejection FractionAnthony P Carnicelli, Zhen Li, Melissa A Greiner, et al.
The American Journal of Cardiology|August 6, 2023
Comparative Outcomes of Sacubitril/Valsartan Use After Hospitalization for Heart Failure Among Medicare Beneficiaries Naïve to Renin-Angiotensin System InhibitorsJacob B Pierce, Vanessa Blumer, Sujung Choi, et al.
American Heart Journal|May 30, 2021
The association of healthcare disparities and patient-specific factors on clinical outcomes in peripheral artery diseaseDennis I Narcisse, Cassie B Ford, E Hope Weissler, et al.
The American Journal of Medicine|October 10, 2021
Clinician Specialty, Access to Care, and Outcomes Among Patients with Peripheral Artery DiseaseE Hope Weissler, Cassie B Ford, Dennis I Narcisse, et al.
Journal of the American Heart Association|February 5, 2019
Relationship Between Hospital Characteristics and Early Adoption of Angiotensin-Receptor/Neprilysin Inhibitor Among Eligible Patients Hospitalized for Heart FailureNancy Luo, Steven J Lippmann, Robert J Mentz, et al.
BMJ Open|January 27, 2023
Construct validity of Patient-Reported Outcomes Measurement Information System Paediatric measures in juvenile idiopathic arthritis and systemic lupus erythematosus: cross-sectional evaluationElissa R Weitzman, Amy Gaultney, Emily von Scheven, et al.
JACC. Heart Failure|April 1, 2017
Early Adoption of Sacubitril/Valsartan for Patients With Heart Failure With Reduced Ejection Fraction: Insights From Get With the Guidelines-Heart Failure (GWTG-HF)Nancy Luo, Gregg C Fonarow, Steven J Lippmann, et al.
Pageof 4